|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review on Maleria, Antimalarial Drug Chloroquine. |
| Authors Name: | Pramod Uddhav Bhamre. , Mrs. Bharti Aher. , Suyog Rajendra Ahire. , Akshay Rajendra Deore. , Nilesh Prakash Pawar. |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_187389
|
| Published Paper Id: | IJNRD2302112 |
| Published In: | Volume 8 Issue 2, February-2023 |
| DOI: | |
| Abstract: | Due to its potential for rapid progression to complications and mortality in the absence of quick and effective treatment, malaria is a medical emergency. Plasmodium falciparum almost exclusively causes severe malaria. In spite of advancements in critical care and antimalarial treatment, imported malaria is becoming more common and its case fatality rate is still high. For many years, the antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been used extensively in the management of autoimmune illnesses as well as the treatment and prevention of malaria. CQ and HCQ have broader therapeutic potential as novel mechanisms of action have been discovered in recent years, one of which being the treatment of viral infectious illnesses. |
| Keywords: | Maleria, Chloroquine, Derivatives, Treatment |
| Cite Article: | "A Review on Maleria, Antimalarial Drug Chloroquine.", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 2, page no.b115-b121, February-2023, Available :http://www.ijnrd.org/papers/IJNRD2302112.pdf |
| Downloads: | 000118746 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2302112 Registration ID: 187389 Published In: Volume 8 Issue 2, February-2023 DOI (Digital Object Identifier): Page No: b115-b121 Country: Abhona, maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2302112 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2302112 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn